{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:39:28Z","timestamp":1783953568858,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1124\/molpharm.122.000542","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T20:20:22Z","timestamp":1658175622000},"page":"106-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Lubiprostone is a Non-Selective Activator of cAMP-Gated Ion Channels and Chloride Channel Protein 2 (Clc-2) Has a Minor Role in its Prosecretory Effect in Intestinal Epithelial Cells"],"prefix":"10.1016","volume":"102","author":[{"given":"Apurva A.","family":"Oak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tifany","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pattareeya","family":"Yottasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parth D.","family":"Chhetri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Du Bois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5178-0199","authenticated-orcid":false,"given":"Onur","family":"Cil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/molpharm.122.000542_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10620-010-1495-8","article-title":"Lubiprostone activates Cl- secretion via cAMP signaling and increases membrane CFTR in the human colon carcinoma cell line, T84","volume":"56","author":"Ao","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1124\/molpharm.122.000542_bib2","doi-asserted-by":"crossref","first-page":"G234","DOI":"10.1152\/ajpgi.00366.2007","article-title":"A synthetic prostone activates apical chloride channels in A6 epithelial cells","volume":"295","author":"Bao","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/molpharm.122.000542_bib3","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1128\/IAI.71.4.2102-2109.2003","article-title":"Salmonella infection induces a hypersecretory phenotype in human intestinal xenografts by inducing cyclooxygenase 2","volume":"71","author":"Bertelsen","year":"2003","journal-title":"Infect Immun"},{"key":"10.1124\/molpharm.122.000542_bib4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.coph.2017.10.015","article-title":"Existing and emerging therapies for managing constipation and diarrhea","volume":"37","author":"Bharucha","year":"2017","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/molpharm.122.000542_bib5","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.gastro.2009.05.037","article-title":"Activation of intestinal Cl- secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator","volume":"137","author":"Bijvelds","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1124\/molpharm.122.000542_bib6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.bjp.0706554","article-title":"RO1138452 and RO3244794: characterization of structurally distinct, potent and selective IP (prostacyclin) receptor antagonists","volume":"147","author":"Bley","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1124\/molpharm.122.000542_bib7","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1053\/j.gastro.2011.10.037","article-title":"Severe defects in absorptive ion transport in distal colons of mice that lack ClC-2 channels","volume":"142","author":"Catal\u00e1n","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1124\/molpharm.122.000542_bib8","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1096\/fj.201600891R","article-title":"Benzopyrimido-pyrrolo-oxazine-dione CFTR inhibitor (R)-BPO-27 for antisecretory therapy of diarrheas caused by bacterial enterotoxins","volume":"31","author":"Cil","year":"2017","journal-title":"FASEB J"},{"key":"10.1124\/molpharm.122.000542_bib9","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.147699","article-title":"SLC26A6-selective inhibitor identified in a small-molecule screen blocks fluid absorption in small intestine","volume":"6","author":"Cil","year":"2021","journal-title":"JCI Insight"},{"key":"10.1124\/molpharm.122.000542_bib10","doi-asserted-by":"crossref","first-page":"C1173","DOI":"10.1152\/ajpcell.00528.2003","article-title":"SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents","volume":"287","author":"Cuppoletti","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1124\/molpharm.122.000542_bib11","doi-asserted-by":"crossref","first-page":"C479","DOI":"10.1152\/ajpcell.00077.2014","article-title":"Differentiation between human ClC-2 and CFTR Cl- channels with pharmacological agents","volume":"307","author":"Cuppoletti","year":"2014","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1124\/molpharm.122.000542_bib12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1476-5381.2010.01058.x","article-title":"Lubiprostone targets prostanoid EP4 receptors in ovine airways","volume":"162","author":"Cuthbert","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1124\/molpharm.122.000542_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcmgh.2018.02.009","article-title":"The Role of Ion Transporters in the Pathophysiology of Infectious Diarrhea","volume":"6","author":"Das","year":"2018","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1124\/molpharm.122.000542_bib14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1474-4422(13)70053-X","article-title":"Brain white matter oedema due to ClC-2 chloride channel deficiency: an observational analytical study","volume":"12","author":"Depienne","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1124\/molpharm.122.000542_bib15","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121370","article-title":"SLC26A3 inhibitor identified in small molecule screen blocks colonic fluid absorption and reduces constipation","volume":"3","author":"Haggie","year":"2018","journal-title":"JCI Insight"},{"key":"10.1124\/molpharm.122.000542_bib16","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1007\/s10620-012-2352-8","article-title":"Lubiprostone targets prostanoid signaling and promotes ion transporter trafficking, mucus exocytosis, and contractility","volume":"57","author":"Jakab","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1124\/molpharm.122.000542_bib17","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s10620-015-3546-7","article-title":"Gastrointestinal Manifestations of Cystic Fibrosis","volume":"60","author":"Kelly","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1124\/molpharm.122.000542_bib18","doi-asserted-by":"crossref","first-page":"32711","DOI":"10.1073\/pnas.2009977117","article-title":"Development and validation of a potent and specific inhibitor for the CLC-2 chloride channel","volume":"117","author":"Koster","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.122.000542_bib19","doi-asserted-by":"crossref","first-page":"8330","DOI":"10.1021\/acs.jmedchem.9b01192","article-title":"4,8-Dimethylcoumarin Inhibitors of Intestinal Anion Exchanger slc26a3 (Downregulated in Adenoma) for Anti-Absorptive Therapy of Constipation","volume":"62","author":"Lee","year":"2019","journal-title":"J Med Chem"},{"key":"10.1124\/molpharm.122.000542_bib20","doi-asserted-by":"crossref","first-page":"C805","DOI":"10.1152\/ajpcell.00291.2001","article-title":"Distribution of ClC-2 chloride channel in rat and human epithelial tissues","volume":"282","author":"Lipecka","year":"2002","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1124\/molpharm.122.000542_bib21","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3389\/fphar.2019.01662","article-title":"CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine","volume":"10","author":"Lopes-Pacheco","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1124\/molpharm.122.000542_bib22","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1172\/JCI0216112","article-title":"Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion","volume":"110","author":"Ma","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1124\/molpharm.122.000542_bib23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.lfs.2014.12.017","article-title":"Prostaglandin D2 regulates human colonic ion transport via the DP1 receptor","volume":"122","author":"Medani","year":"2015","journal-title":"Life Sci"},{"key":"10.1124\/molpharm.122.000542_bib24","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1111\/bph.12726","article-title":"Revisiting CFTR inhibition: a comparative study of CFTRinh -172 and GlyH-101 inhibitors","volume":"171","author":"Melis","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1124\/molpharm.122.000542_bib25","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1124\/molpharm.122.000542_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejphar.2016.12.004","article-title":"Eicosanoid receptors: Targets for the treatment of disrupted intestinal epithelial homeostasis","volume":"796","author":"Moreno","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/molpharm.122.000542_bib27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1742-7843.2008.00257.x","article-title":"EP4 and EP2 receptor subtypes involved in colonic secretion in rat","volume":"103","author":"Mosa","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1124\/molpharm.122.000542_bib28","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/S1569-1993(21)01631-3","article-title":"206: Gastrointestinal symptoms are common in people with cystic fibrosis regardless of gastrointestinal medication usage: Results from GALAXY","volume":"20","author":"Moshiree","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1124\/molpharm.122.000542_bib29","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1016\/S1569-1993(21)01633-7","article-title":"208: Effects of tezacaftor\/ivacaftor on gut function and transit in cystic fibrosis: A randomized, double-blind, placebo-controlled, crossover trial","volume":"20","author":"Ng","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1124\/molpharm.122.000542_bib30","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.bbrc.2012.08.097","article-title":"Lubiprostone activates CFTR, but not ClC-2, via the prostaglandin receptor (EP(4))","volume":"426","author":"Norimatsu","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/molpharm.122.000542_bib31","article-title":"Repurposing calcium-sensing receptor agonist cinacalcet for treatment of CFTR-mediated secretory diarrheas","volume":"6","author":"Oak","year":"2021","journal-title":"JCI Insight"},{"key":"10.1124\/molpharm.122.000542_bib32","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1345\/aph.1Q219","article-title":"Lubiprostone for constipation in adults with cystic fibrosis: a pilot study","volume":"45","author":"O\u2019Brien","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1124\/molpharm.122.000542_bib33","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/cphy.c180011","article-title":"Physiology of Electrolyte Transport in the Gut: Implications for Disease","volume":"9","author":"Rao","year":"2019","journal-title":"Compr Physiol"},{"key":"10.1124\/molpharm.122.000542_bib34","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1172\/JCI119866","article-title":"The antifungal antibiotic, clotrimazole, inhibits chloride secretion by human intestinal T84 cells via blockade of distinct basolateral K+ conductances. Demonstration of efficacy in intact rabbit colon and in an in vivo mouse model of cholera","volume":"100","author":"Rufo","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1124\/molpharm.122.000542_bib35","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.95.7.3879","article-title":"Analysis of ClC-2 channels as an alternative pathway for chloride conduction in cystic fibrosis airway cells","volume":"95","author":"Schwiebert","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.122.000542_bib36","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1124\/jpet.103.055442","article-title":"Chemoattractant receptor-homologous molecule expressed on Th2 cells activation in vivo increases blood leukocyte counts and its blockade abrogates 13,14-dihydro-15-keto-prostaglandin D2-induced eosinophilia in rats","volume":"307","author":"Shichijo","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/molpharm.122.000542_bib37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/356057a0","article-title":"A chloride channel widely expressed in epithelial and non-epithelial cells","volume":"356","author":"Thiemann","year":"1992","journal-title":"Nature"},{"key":"10.1124\/molpharm.122.000542_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jcf.2009.11.003","article-title":"Constipation in pediatric cystic fibrosis patients: an underestimated medical condition","volume":"9","author":"van der Doef","year":"2010","journal-title":"J Cyst Fibros"},{"key":"10.1124\/molpharm.122.000542_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3892\/mmr.2017.6600","article-title":"Research and progress on ClC-2","volume":"16","author":"Wang","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1124\/molpharm.122.000542_bib40","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/sj.bjp.0706726","article-title":"GW627368X ((N-{2-[4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist","volume":"148","author":"Wilson","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1124\/molpharm.122.000542_bib41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/2040622314567678","article-title":"Lubiprostone in constipation: clinical evidence and place in therapy","volume":"6","author":"Wilson","year":"2015","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1124\/molpharm.122.000542_bib42","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/0006-2952(95)02035-7","article-title":"6-Isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809), a human EP2 receptor antagonist","volume":"50","author":"Woodward","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/molpharm.122.000542_bib43","doi-asserted-by":"crossref","first-page":"22276","DOI":"10.1074\/jbc.M309899200","article-title":"Additional disruption of the ClC-2 Cl(-) channel does not exacerbate the cystic fibrosis phenotype of cystic fibrosis transmembrane conductance regulator mouse models","volume":"279","author":"Zdebik","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.122.000542_bib44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-0270(98)00019-3","article-title":"Identification of endogenous outward currents in the human embryonic kidney (HEK 293) cell line","volume":"81","author":"Zhu","year":"1998","journal-title":"J Neurosci Methods"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24012513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24012513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/molpharm.122.000542","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:29:00Z","timestamp":1739957340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24012513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0026895X24012513"],"URL":"https:\/\/doi.org\/10.1124\/molpharm.122.000542","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lubiprostone is a Non-Selective Activator of cAMP-Gated Ion Channels and Chloride Channel Protein 2 (Clc-2) Has a Minor Role in its Prosecretory Effect in Intestinal Epithelial Cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/molpharm.122.000542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}